Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Spectral Medical Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(335)
•••
Post by hmmmmmmmmon Jan 19, 2023 9:22pm
374 Views
Post# 35234682

Home Dialysis Pump Trial Completed

Home Dialysis Pump Trial Completed

The Deka pump home use trial enrolled it’s last of 70 patients on July 15th.

 

And the Quanta SC+ home use trial added their 11th site in December.

 

 

Congrats. With Covid and staff shortages we were told it couldn’t be done. (cough, cough)

 

 

 

https://www.clinicaltrials.gov/ct2/show/record/NCT04087213?term=deka&cntry=US&draw=3&rank=9

 

https://www.clinicaltrials.gov/ct2/show/NCT04975880?term=quanta+sc%2B&cntry=US&draw=2&rank=1

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities